BioNexus Gene Lab (BGLC) FCF Payout Ratio (2023 - 2024)
BioNexus Gene Lab recorded quarterly FCF Payout Ratio of 0.0 in Q3 2024, up 50.46% quarter-over-quarter from 0.0 in Q2 2024, and up 47.48% year-over-year from 0.0 in Q4 2023.
BioNexus Gene Lab's FCF Payout Ratio history runs 2 years deep, the most recent figure standing at 0.0 for Q3 2024.
- In Q3 2024, FCF Payout Ratio rose 47.48% year-over-year to 0.0; the TTM figure through Sep 2024 stood at 0.0 (changed N/A YoY), while the FY2023 annual figure was 0.0, down 131.88% from the prior year.
- FCF Payout Ratio came in at 0.0 for Q3 2024 at BioNexus Gene Lab, up from 0.0 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 0.0 in Q3 2024 to a low of 0.05 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 0.83 |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | - |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 246.38 |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 0.25 |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 0.36 |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | -8.37 |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | -0.42 |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 0.15 |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 0.63 |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | -0.05 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -0.04 |
| Mar 31, 2023 | -0.02 |